Is the Cardiac Amyloidosis Artificial Intelligence Electrocardiography (CA-AI-ECG) model useful in predicting outcomes in Multiple Myeloma (MM) patients without known Amyloidosis undergoing Autologous Stem Cell Transplant (ASCT)? PA114 (#160)